# Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases

> **NIH NIH R01** · UNIVERSITY OF COLORADO DENVER · 2024 · $611,072


## Key facts

- **NIH application ID:** 10744762
- **Project number:** 5R01HL158076-03
- **Recipient organization:** UNIVERSITY OF COLORADO DENVER
- **Principal Investigator:** Paul Werner Buehler
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $611,072
- **Award type:** 5
- **Project period:** 2021-12-01 → 2025-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10744762

## Citation

> US National Institutes of Health, RePORTER application 10744762, Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases (5R01HL158076-03). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10744762. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*